vs
Side-by-side financial comparison of Alignment Healthcare, Inc. (ALHC) and DONALDSON Co INC (DCI). Click either name above to swap in a different company.
Alignment Healthcare, Inc. is the larger business by last-quarter revenue ($1.0B vs $935.4M, roughly 1.1× DONALDSON Co INC). DONALDSON Co INC runs the higher net margin — 12.2% vs -1.1%, a 13.3% gap on every dollar of revenue. On growth, Alignment Healthcare, Inc. posted the faster year-over-year revenue change (44.4% vs 3.9%). DONALDSON Co INC produced more free cash flow last quarter ($111.2M vs $-55.4M). Over the past eight quarters, Alignment Healthcare, Inc.'s revenue compounded faster (26.9% CAGR vs 3.3%).
Alignment Healthcare, Inc. is a U.S.-based healthcare provider offering Medicare Advantage plans for seniors. It adopts a value-based care model, partnering with local providers to deliver personalized coordinated medical services, prescription drug coverage and supplemental benefits to members across multiple U.S. states.
Donaldson Company, Inc. is a filtration company engaged in the production and marketing of filtration products used in a variety of industry sectors, including commercial/industrial, aerospace, chemical, alternative energy (windmills), food & beverage, and pharmaceuticals. Also the company's research division, located in Minneapolis, Minn., participated in defense-related projects for various military applications.
ALHC vs DCI — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $1.0B | $935.4M |
| Net Profit | $-11.0M | $113.9M |
| Gross Margin | — | 35.2% |
| Operating Margin | -1.0% | 16.0% |
| Net Margin | -1.1% | 12.2% |
| Revenue YoY | 44.4% | 3.9% |
| Net Profit YoY | 64.6% | 15.1% |
| EPS (diluted) | $-0.04 | $0.97 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $1.0B | $935.4M | ||
| Q3 25 | $993.7M | $980.7M | ||
| Q2 25 | $1.0B | $940.1M | ||
| Q1 25 | $926.9M | $870.0M | ||
| Q4 24 | $701.2M | $900.1M | ||
| Q3 24 | $692.4M | $935.4M | ||
| Q2 24 | $681.3M | $927.9M | ||
| Q1 24 | $628.6M | $876.7M |
| Q4 25 | $-11.0M | $113.9M | ||
| Q3 25 | $3.7M | $114.3M | ||
| Q2 25 | $15.7M | $57.8M | ||
| Q1 25 | $-9.1M | $95.9M | ||
| Q4 24 | $-31.1M | $99.0M | ||
| Q3 24 | $-26.4M | $109.7M | ||
| Q2 24 | $-24.0M | $113.5M | ||
| Q1 24 | $-46.5M | $98.7M |
| Q4 25 | — | 35.2% | ||
| Q3 25 | — | 34.5% | ||
| Q2 25 | — | 34.2% | ||
| Q1 25 | — | 35.2% | ||
| Q4 24 | — | 35.5% | ||
| Q3 24 | — | 35.8% | ||
| Q2 24 | — | 35.6% | ||
| Q1 24 | — | 35.2% |
| Q4 25 | -1.0% | 16.0% | ||
| Q3 25 | 0.8% | 15.5% | ||
| Q2 25 | 2.2% | 9.3% | ||
| Q1 25 | -0.6% | 14.4% | ||
| Q4 24 | -3.2% | 14.5% | ||
| Q3 24 | -2.8% | 15.6% | ||
| Q2 24 | -2.7% | 15.5% | ||
| Q1 24 | -6.5% | 14.8% |
| Q4 25 | -1.1% | 12.2% | ||
| Q3 25 | 0.4% | 11.7% | ||
| Q2 25 | 1.5% | 6.1% | ||
| Q1 25 | -1.0% | 11.0% | ||
| Q4 24 | -4.4% | 11.0% | ||
| Q3 24 | -3.8% | 11.7% | ||
| Q2 24 | -3.5% | 12.2% | ||
| Q1 24 | -7.4% | 11.3% |
| Q4 25 | $-0.04 | $0.97 | ||
| Q3 25 | $0.02 | $0.97 | ||
| Q2 25 | $0.07 | $0.48 | ||
| Q1 25 | $-0.05 | $0.79 | ||
| Q4 24 | $-0.15 | $0.81 | ||
| Q3 24 | $-0.14 | $0.90 | ||
| Q2 24 | $-0.13 | $0.92 | ||
| Q1 24 | $-0.25 | $0.81 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $604.2M | $210.7M |
| Total DebtLower is stronger | $323.2M | $671.5M |
| Stockholders' EquityBook value | $179.3M | $1.5B |
| Total Assets | $1.1B | $3.0B |
| Debt / EquityLower = less leverage | 1.80× | 0.44× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $604.2M | $210.7M | ||
| Q3 25 | $644.1M | $180.4M | ||
| Q2 25 | $503.8M | $178.5M | ||
| Q1 25 | $479.5M | $189.1M | ||
| Q4 24 | $470.6M | $221.2M | ||
| Q3 24 | $381.0M | $232.7M | ||
| Q2 24 | $363.7M | $223.7M | ||
| Q1 24 | $301.7M | $193.8M |
| Q4 25 | $323.2M | $671.5M | ||
| Q3 25 | $322.7M | $630.4M | ||
| Q2 25 | $322.3M | $638.8M | ||
| Q1 25 | $321.9M | $514.7M | ||
| Q4 24 | $321.4M | $538.6M | ||
| Q3 24 | $212.0M | $483.4M | ||
| Q2 24 | $211.7M | $481.8M | ||
| Q1 24 | $162.0M | $352.0M |
| Q4 25 | $179.3M | $1.5B | ||
| Q3 25 | $161.9M | $1.5B | ||
| Q2 25 | $141.0M | $1.5B | ||
| Q1 25 | $108.1M | $1.5B | ||
| Q4 24 | $99.9M | $1.5B | ||
| Q3 24 | $114.5M | $1.5B | ||
| Q2 24 | $123.7M | $1.5B | ||
| Q1 24 | $130.9M | $1.4B |
| Q4 25 | $1.1B | $3.0B | ||
| Q3 25 | $1.1B | $3.0B | ||
| Q2 25 | $1.0B | $3.0B | ||
| Q1 25 | $895.6M | $3.0B | ||
| Q4 24 | $782.1M | $3.0B | ||
| Q3 24 | $692.3M | $2.9B | ||
| Q2 24 | $716.3M | $2.9B | ||
| Q1 24 | $633.2M | $2.8B |
| Q4 25 | 1.80× | 0.44× | ||
| Q3 25 | 1.99× | 0.43× | ||
| Q2 25 | 2.29× | 0.44× | ||
| Q1 25 | 2.98× | 0.33× | ||
| Q4 24 | 3.22× | 0.35× | ||
| Q3 24 | 1.85× | 0.32× | ||
| Q2 24 | 1.71× | 0.32× | ||
| Q1 24 | 1.24× | 0.26× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-50.4M | $125.4M |
| Free Cash FlowOCF − Capex | $-55.4M | $111.2M |
| FCF MarginFCF / Revenue | -5.5% | 11.9% |
| Capex IntensityCapex / Revenue | 0.5% | 1.5% |
| Cash ConversionOCF / Net Profit | — | 1.10× |
| TTM Free Cash FlowTrailing 4 quarters | $113.1M | $403.2M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-50.4M | $125.4M | ||
| Q3 25 | $144.6M | $167.8M | ||
| Q2 25 | $29.1M | $87.7M | ||
| Q1 25 | $16.6M | $90.4M | ||
| Q4 24 | $-8.7M | $72.9M | ||
| Q3 24 | $26.2M | $126.0M | ||
| Q2 24 | $23.5M | $141.5M | ||
| Q1 24 | $-6.2M | $87.0M |
| Q4 25 | $-55.4M | $111.2M | ||
| Q3 25 | $139.1M | $147.5M | ||
| Q2 25 | $21.1M | $73.0M | ||
| Q1 25 | $8.4M | $71.5M | ||
| Q4 24 | $-18.0M | $47.9M | ||
| Q3 24 | $16.9M | $106.2M | ||
| Q2 24 | $11.8M | $120.2M | ||
| Q1 24 | $-17.4M | $65.7M |
| Q4 25 | -5.5% | 11.9% | ||
| Q3 25 | 14.0% | 15.0% | ||
| Q2 25 | 2.1% | 7.8% | ||
| Q1 25 | 0.9% | 8.2% | ||
| Q4 24 | -2.6% | 5.3% | ||
| Q3 24 | 2.4% | 11.4% | ||
| Q2 24 | 1.7% | 13.0% | ||
| Q1 24 | -2.8% | 7.5% |
| Q4 25 | 0.5% | 1.5% | ||
| Q3 25 | 0.6% | 2.1% | ||
| Q2 25 | 0.8% | 1.6% | ||
| Q1 25 | 0.9% | 2.2% | ||
| Q4 24 | 1.3% | 2.8% | ||
| Q3 24 | 1.3% | 2.1% | ||
| Q2 24 | 1.7% | 2.3% | ||
| Q1 24 | 1.8% | 2.4% |
| Q4 25 | — | 1.10× | ||
| Q3 25 | 38.77× | 1.47× | ||
| Q2 25 | 1.86× | 1.52× | ||
| Q1 25 | — | 0.94× | ||
| Q4 24 | — | 0.74× | ||
| Q3 24 | — | 1.15× | ||
| Q2 24 | — | 1.25× | ||
| Q1 24 | — | 0.88× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ALHC
Segment breakdown not available.
DCI
| Aftermarket Products | $447.1M | 48% |
| Industrial Filtration Solutions Products | $222.6M | 24% |
| Off Road Products | $86.5M | 9% |
| Life Sciences Segment | $80.0M | 9% |
| Other | $39.1M | 4% |
| Aerospace And Defense Products | $37.1M | 4% |
| On Road Products | $23.0M | 2% |
